The optimal timing of breast cancer surgery after COVID-19 infection: an observational study
It needs to be cautious when breast cancer surgery was performed within 2 weeks after COVID-19 infection. Although the incidence of complications in patients undergoing surgery 2 weeks after COVID-19 infection is still slightly high, surgery might be recommended considering urgency of treatment, good prognosis of complications and the lack of influence on subsequent adjuvant therapy.
Authors
- Wei-Hao Cheng
- Zhao Bi (ORCID: https://orcid.org/0000-0001-9546-1704)
- Wenhao Zheng (ORCID: https://orcid.org/0000-0002-9618-2456)
- Pengfei Qiu (ORCID: https://orcid.org/0000-0001-8644-1445)
- Yong-Sheng Wang
- Wei-Li Wang (ORCID: https://orcid.org/0009-0009-7221-5610)
- Peng Chen (ORCID: https://orcid.org/0000-0001-8462-2875)
- Yanbing Liu (ORCID: https://orcid.org/0000-0001-9849-7948)
- Tong-Yue Ren
Institutions
- People’s Hospital of Rizhao (CN)
- Shandong Tumor Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-03
- DOI
- https://doi.org/10.1186/s12885-024-13080-1
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- China Postdoctoral Science Foundation